BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25597287)

  • 1. A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.
    León-Mimila P; Vega-Badillo J; Gutiérrez-Vidal R; Villamil-Ramírez H; Villareal-Molina T; Larrieta-Carrasco E; López-Contreras BE; Kauffer LR; Maldonado-Pintado DG; Méndez-Sánchez N; Tovar AR; Hernández-Pando R; Velázquez-Cruz R; Campos-Pérez F; Aguilar-Salinas CA; Canizales-Quinteros S
    Exp Mol Pathol; 2015 Apr; 98(2):178-83. PubMed ID: 25597287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
    Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
    Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
    Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
    Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
    Speliotes EK; Yerges-Armstrong LM; Wu J; Hernaez R; Kim LJ; Palmer CD; Gudnason V; Eiriksdottir G; Garcia ME; Launer LJ; Nalls MA; Clark JM; Mitchell BD; Shuldiner AR; Butler JL; Tomas M; Hoffmann U; Hwang SJ; Massaro JM; O'Donnell CJ; Sahani DV; Salomaa V; Schadt EE; Schwartz SM; Siscovick DS; ; ; ; Voight BF; Carr JJ; Feitosa MF; Harris TB; Fox CS; Smith AV; Kao WH; Hirschhorn JN; Borecki IB;
    PLoS Genet; 2011 Mar; 7(3):e1001324. PubMed ID: 21423719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.
    Di Costanzo A; Belardinilli F; Bailetti D; Sponziello M; D'Erasmo L; Polimeni L; Baratta F; Pastori D; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Giannini G; Del Ben M; Angelico F; Arca M
    Sci Rep; 2018 Feb; 8(1):3702. PubMed ID: 29487372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.
    Gorden A; Yang R; Yerges-Armstrong LM; Ryan KA; Speliotes E; Borecki IB; Harris TB; Chu X; Wood GC; Still CD; Shuldiner AR; Gerhard GS;
    Hum Hered; 2013; 75(1):34-43. PubMed ID: 23594525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
    Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
    J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
    Sliz E; Sebert S; Würtz P; Kangas AJ; Soininen P; Lehtimäki T; Kähönen M; Viikari J; Männikkö M; Ala-Korpela M; Raitakari OT; Kettunen J
    Hum Mol Genet; 2018 Jun; 27(12):2214-2223. PubMed ID: 29648650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
    Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
    Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
    Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
    Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
    Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
    Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
    Shang XR; Song JY; Liu FH; Ma J; Wang HJ
    J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.
    Wruck W; Kashofer K; Rehman S; Daskalaki A; Berg D; Gralka E; Jozefczuk J; Drews K; Pandey V; Regenbrecht C; Wierling C; Turano P; Korf U; Zatloukal K; Lehrach H; Westerhoff HV; Adjaye J
    Sci Data; 2015 Dec; 2():150068. PubMed ID: 26646939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
    PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
    Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    Dold L; Luda C; Schwarze-Zander C; Boesecke C; Hansel C; Nischalke HD; Lutz P; Mohr R; Wasmuth JC; Strassburg CP; Trebicka J; Rockstroh JK; Spengler U
    PLoS One; 2017; 12(6):e0178685. PubMed ID: 28594920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups.
    Boonvisut S; Nakayama K; Makishima S; Watanabe K; Miyashita H; Lkhagvasuren M; Kagawa Y; Iwamoto S
    Lipids Health Dis; 2016 Jan; 15():8. PubMed ID: 26758378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.